A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours
Clinical trial NCT06873854 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06873854
- Sponsor
- LaNova Medicines Limited
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-26
- Primary completion
- 2028-01-26
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.